Clinical Trials List
Protocol NumberTAS-117-201
Completed
2022-08-22 - 2026-07-31
Phase II
Recruiting1
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 白哲聲 Division of Endocrinology
- Shen Liang Shih Division of General Surgery
- Shang-Jyh Hwang Division of Endocrinology
- Ching-Chia Li Division of Urology
- Chieh-Han Chuang Division of General Surgery
- Cheng-Yu Long Division of Obstetrics & Gynecology
- Wen-Jeng Wu Division of Urology
- 高育青 Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
- Hui-Ching Wang Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
100 participants
